113 related articles for article (PubMed ID: 23029524)
21. Bmi1 drives hepatocarcinogenesis by repressing the TGFβ2/SMAD signalling axis.
Li B; Chen Y; Wang F; Guo J; Fu W; Li M; Zheng Q; Liu Y; Fan L; Li L; Xu C
Oncogene; 2020 Jan; 39(5):1063-1079. PubMed ID: 31591477
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.
Bartucci M; Hussein MS; Huselid E; Flaherty K; Patrizii M; Laddha SV; Kui C; Bigos RA; Gilleran JA; El Ansary MMS; Awad MAM; Kimball SD; Augeri DJ; Sabaawy HE
Target Oncol; 2017 Aug; 12(4):449-462. PubMed ID: 28589491
[TBL] [Abstract][Full Text] [Related]
23. Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice.
Crawford DR; Ilic Z; Guest I; Milne GL; Hayes JD; Sell S
Carcinogenesis; 2017 Jul; 38(7):717-727. PubMed ID: 28535182
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of Bmi1 promotes malignant transformation of hepatic progenitor cells.
Zhang R; Wu WR; Shi XD; Xu LB; Zhu MS; Zeng H; Liu C
Oncogenesis; 2016 Feb; 5(2):e203. PubMed ID: 26926789
[TBL] [Abstract][Full Text] [Related]
25. Biological effects of pyrroloquinoline quinone on liver damage in Bmi-1 knockout mice.
Huang Y; Chen N; Miao D
Exp Ther Med; 2015 Aug; 10(2):451-458. PubMed ID: 26622336
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
27. Growth Arrest Specific 1 (Gas1) Gene Overexpression in Liver Reduces the In Vivo Progression of Murine Hepatocellular Carcinoma and Partially Restores Gene Expression Levels.
Sacilotto N; Castillo J; Riffo-Campos ÁL; Flores JM; Hibbitt O; Wade-Martins R; López C; Rodrigo MI; Franco L; López-Rodas G
PLoS One; 2015; 10(7):e0132477. PubMed ID: 26161998
[TBL] [Abstract][Full Text] [Related]
28. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
[TBL] [Abstract][Full Text] [Related]
29. The Polycomb protein, Bmi1, regulates insulin sensitivity.
Cannon CE; Titchenell PM; Groff DN; El Ouaamari A; Kulkarni RN; Birnbaum MJ; Stoffers DA
Mol Metab; 2014 Nov; 3(8):794-802. PubMed ID: 25379404
[TBL] [Abstract][Full Text] [Related]
30. Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo.
Yang T; Li B; Qi S; Liu Y; Gai Y; Ye P; Yang G; Zhang W; Zhang P; He X; Li W; Zhang Z; Xiang G; Xu C
Theranostics; 2014; 4(11):1096-111. PubMed ID: 25285163
[TBL] [Abstract][Full Text] [Related]
31. p21/Cyclin E pathway modulates anticlastogenic function of Bmi-1 in cancer cells.
Deng W; Zhou Y; Tiwari AF; Su H; Yang J; Zhu D; Lau VM; Hau PM; Yip YL; Cheung AL; Guan XY; Tsao SW
Int J Cancer; 2015 Mar; 136(6):1361-70. PubMed ID: 25131797
[TBL] [Abstract][Full Text] [Related]
32. Hydrodynamic transfection for generation of novel mouse models for liver cancer research.
Chen X; Calvisi DF
Am J Pathol; 2014 Apr; 184(4):912-923. PubMed ID: 24480331
[TBL] [Abstract][Full Text] [Related]
33. The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells.
Shin S; Kaestner KH
Curr Top Dev Biol; 2014; 107():269-92. PubMed ID: 24439810
[TBL] [Abstract][Full Text] [Related]
34. SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.
Li L; Wang C; Calvisi DF; Evert M; Pilo MG; Jiang L; Yuneva M; Chen X
PLoS One; 2013; 8(9):e75104. PubMed ID: 24069385
[TBL] [Abstract][Full Text] [Related]
35. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
[TBL] [Abstract][Full Text] [Related]
36. Bmi1 is required for hepatic progenitor cell expansion and liver tumor development.
Fan L; Xu C; Wang C; Tao J; Ho C; Jiang L; Gui B; Huang S; Evert M; Calvisi DF; Chen X
PLoS One; 2012; 7(9):e46472. PubMed ID: 23029524
[TBL] [Abstract][Full Text] [Related]
37. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
38. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
Xu CR; Lee S; Ho C; Bommi P; Huang SA; Cheung ST; Dimri GP; Chen X
Mol Cancer Res; 2009 Dec; 7(12):1937-45. PubMed ID: 19934271
[TBL] [Abstract][Full Text] [Related]
39. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
[TBL] [Abstract][Full Text] [Related]
40. A protein synthesis brake for hematopoietic stem cell maintenance.
Lv K; Tong W
Genes Dev; 2022 Aug; 36(15-16):871-873. PubMed ID: 36207141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
